7th Mar 2017 10:54
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:
| Faron Pharmaceuticals Oy | |||
2. Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.
| ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
| ||||
An event changing the breakdown of voting rights | Yes | |||
Other (please specify):
| ||||
3. Full name of person(s) subject to thenotification obligation: |
Legal & General Group Plc (L&G)
Legal & General (Unit Trust Managers) Limited (UTM)
| |||
4. Full name of shareholder(s) (if different from 3.): |
N/A
| |||
5. Date of the transaction and date onwhich the threshold is crossed orreached:
| 03 March 2017 | |||
6. Date on which issuer notified: | 07 March 2017 | |||
7. Threshold(s) that is/are crossed orreached:
| UTM (Below 5%) | |||
8. Notified details:
| ||||||||||||||||
A: Voting rights attached to shares | ||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||
NumberofShares | NumberofVotingRights |
Numberof shares | Number of votingrights | % of voting rights | ||||||||||||
Direct | Indirect | Direct | Indirect | |||||||||||||
ORD NPV | 1,365,000.00 | Below 5% | - | Below 5% | - | Below 5% | ||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument |
Expirationdate |
Exercise/Conversion Period | Number of votingrights that may beacquired if theinstrument isexercised/ converted. |
% of votingrights | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument
|
Exercise price |
Expiration date |
Exercise/Conversion period |
Number of voting rights instrument refers to
|
% of voting rights
| |||||||||||
| Nominal | Delta | ||||||||||||||
| ||||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
UTM (Below 5%) | ||||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | |||||||||||||||||||||||
| |||||||||||||||||||||||
Proxy Voting: | |||||||||||||||||||||||
10. Name of the proxy holder: | N/A | ||||||||||||||||||||||
11. Number of voting rights proxy holder will ceaseto hold: | N/A | ||||||||||||||||||||||
12. Date on which proxy holder will cease to holdvoting rights: | N/A | ||||||||||||||||||||||
| |||||||||||||||||||||||
13. Additional information: | Notification using the total voting rights figure of 27,734,044 | ||||||||||||||||||||||
14. Contact name: | Victoria Davies (LGIM) | ||||||||||||||||||||||
15. Contact telephone number: | 029 2035 4147 | ||||||||||||||||||||||
Related Shares:
Faron PharmaceuticalsLegal & General